MedPath

YUFLYMA

YUFLYMA

Approved
DIN Number

02535084

Drug Class

Human

Market Date

Aug 14, 2023

Company
HC

Celltrion Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02535084
AIG Number0150364002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AB04 ADALIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ADALIMUMABActive
Strength: 80 MG / 0.8 ML
Monograph: ADALIMUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.